Monopar Therapeutics (MNPR) Enterprise Value Growth (1y) (2017 - 2025)
Monopar Therapeutics (MNPR) Enterprise Value Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Monopar Therapeutics |
441.25 Mn |
441.25 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-34.96% |
| Sep 30, 2025 |
-2,020.86% |
| Jun 30, 2025 |
-545.46% |
| Mar 31, 2025 |
-408.63% |
| Dec 31, 2024 |
-530.55% |
| Sep 30, 2024 |
-9.15% |
| Jun 30, 2024 |
15.17% |
| Mar 31, 2024 |
-36.36% |
| Dec 31, 2023 |
11.24% |
| Sep 30, 2023 |
60.39% |
| Jun 30, 2023 |
56.18% |
| Mar 31, 2023 |
67.87% |
| Dec 31, 2022 |
59.10% |
| Sep 30, 2022 |
37.68% |
| Jun 30, 2022 |
30.95% |
| Mar 31, 2022 |
30.73% |
| Dec 31, 2021 |
-19.58% |
| Sep 30, 2021 |
-24.24% |
| Jun 30, 2021 |
-90.04% |
| Mar 31, 2021 |
-104.28% |
